KIDS Stock Forecast 2025-2026
Distance to KIDS Price Targets
KIDS Price Momentum
🤔 Considering OrthoPediatrics (KIDS)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest KIDS Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, KIDS has a bullish consensus with a median price target of $41.00 (ranging from $26.00 to $50.00). The overall analyst rating is Strong Buy (8.3/10). Currently trading at $25.08, the median forecast implies a 63.5% upside. This outlook is supported by 5 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from David Turkaly at JMP Securities, projecting a 99.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
KIDS Analyst Ratings
KIDS Price Target Range
Latest KIDS Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for KIDS.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Mar 5, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Mar 5, 2025 | Stifel | Rick Wise | Buy | Maintains | $32.00 |
| Jan 14, 2025 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Dec 18, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $25.00 |
| Nov 8, 2024 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Oct 14, 2024 | Truist Securities | Richard Newitter | Hold | Maintains | $28.00 |
| Sep 13, 2024 | Truist Securities | Richard Newitter | Hold | Reiterates | $34.00 |
| Sep 13, 2024 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Sep 13, 2024 | JMP Securities | David Turkaly | Market Outperform | Reiterates | $50.00 |
| Aug 16, 2024 | Needham | Mike Matson | Buy | Reiterates | $42.00 |
| Aug 8, 2024 | Truist Securities | Richard Newitter | Hold | Reiterates | $30.00 |
| Jul 16, 2024 | Truist Securities | Samuel Brodovsky | Hold | Maintains | $35.00 |
| May 8, 2024 | Truist Securities | Samuel Brodovsky | Hold | Maintains | $38.00 |
| May 7, 2024 | Needham | Mike Matson | Buy | Maintains | $42.00 |
| May 7, 2024 | JMP Securities | David Turkaly | Market Outperform | Reiterates | $50.00 |
| Apr 10, 2024 | Needham | Mike Matson | Buy | Reiterates | $37.00 |
| Mar 27, 2024 | Piper Sandler | Overweight | Reiterates | $0.00 | |
| Mar 8, 2024 | Truist Securities | Samuel Brodovsky | Hold | Maintains | $32.00 |
| Mar 7, 2024 | Stifel | Rick Wise | Buy | Maintains | $34.00 |
| Mar 7, 2024 | Needham | Mike Matson | Buy | Reiterates | $37.00 |
OrthoPediatrics Corp. (KIDS) Competitors
The following stocks are similar to OrthoPediatrics based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
OrthoPediatrics Corp. (KIDS) Financial Data
OrthoPediatrics Corp. has a market capitalization of $609.11M with a P/E ratio of 246.3x. The company generates $204.73M in trailing twelve-month revenue with a -18.5% profit margin.
Revenue growth is +40.0% quarter-over-quarter, while maintaining an operating margin of -16.3% and return on equity of -10.3%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
OrthoPediatrics Corp. (KIDS) Business Model
About OrthoPediatrics Corp.
Develops orthopedic devices for pediatric patients.
The company generates revenue by designing, developing, and marketing specialized orthopedic medical devices tailored for children. Its product offerings cater to hospitals and orthopedic surgeons, focusing on treating musculoskeletal conditions, trauma, deformity correction, and complex spine issues in the pediatric demographic.
OrthoPediatrics Corp. occupies a unique niche in the medical device industry by exclusively addressing the needs of children, which are often overlooked. Its commitment to safety and efficacy in product design not only enhances the quality of pediatric care but also positions the company to improve long-term health outcomes for young patients globally.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
562
CEO
Mr. David R. Bailey
Country
United States
IPO Year
2017
Website
www.orthopediatrics.comOrthoPediatrics Corp. (KIDS) Latest News & Analysis
OrthoPediatrics Corp. (NASDAQ: KIDS) will host its Q4 2024 earnings conference call on March 4, 2025, at 4:30 PM ET, featuring key executives and analysts.
OrthoPediatrics' earnings call will provide insights into financial performance, growth strategies, and market outlook, influencing stock valuation and investor sentiment.
OrthoPediatrics reported record 2024 revenue of $204.7 million, a 38% increase year-over-year, and a doubling of fourth quarter adjusted EBITDA.
Record revenue growth of 38% and a doubling of adjusted EBITDA signal strong financial health and operational efficiency, potentially boosting investor confidence and stock performance.
OrthoPediatrics (KIDS) reported quarterly results for December 2024. Investors should compare key metrics against Wall Street estimates and year-ago figures for a comprehensive understanding.
Comparing OrthoPediatrics' performance metrics to Wall Street estimates and previous years provides insights into growth, profitability, and market expectations, influencing investment decisions.
OrthoPediatrics (KIDS) reported a quarterly loss of $0.29 per share, exceeding the Zacks estimate of $0.22, and worsening from a loss of $0.23 per share a year prior.
OrthoPediatrics' larger-than-expected quarterly loss may indicate operational challenges, potentially leading to decreased investor confidence and impacting stock performance.
OrthoPediatrics Corp. to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
24 days agoOrthoPediatrics Corp. (Nasdaq: KIDS) will release its Q4 and full year 2024 financial results on March 4, 2025, after market close, followed by a conference call at 4:30 p.m. ET.
OrthoPediatrics' upcoming financial results and conference call may indicate performance trends, influencing stock valuation and investor sentiment in the pediatric orthopedic sector.
OrthoPediatrics Corp. (Nasdaq: KIDS) announced it has acquired distribution rights for new bracing solutions in the US via its OrthoPediatrics Specialty Bracing division.
OrthoPediatrics expanding its product offerings with new bracing solutions enhances its market position and growth potential, impacting revenue and investor confidence in future performance.
Frequently Asked Questions About KIDS Stock
What is OrthoPediatrics Corp.'s (KIDS) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, OrthoPediatrics Corp. (KIDS) has a median price target of $41.00. The highest price target is $50.00 and the lowest is $26.00.
Is KIDS stock a good investment in 2025?
According to current analyst ratings, KIDS has 5 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $25.08. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for KIDS stock?
Wall Street analysts predict KIDS stock could reach $41.00 in the next 12 months. This represents a 63.5% increase from the current price of $25.08. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is OrthoPediatrics Corp.'s business model?
The company generates revenue by designing, developing, and marketing specialized orthopedic medical devices tailored for children. Its product offerings cater to hospitals and orthopedic surgeons, focusing on treating musculoskeletal conditions, trauma, deformity correction, and complex spine issues in the pediatric demographic.
What is the highest forecasted price for KIDS OrthoPediatrics Corp.?
The highest price target for KIDS is $50.00 from David Turkaly at JMP Securities, which represents a 99.4% increase from the current price of $25.08.
What is the lowest forecasted price for KIDS OrthoPediatrics Corp.?
The lowest price target for KIDS is $26.00 from at , which represents a 3.7% increase from the current price of $25.08.
What is the overall KIDS consensus from analysts for OrthoPediatrics Corp.?
The overall analyst consensus for KIDS is bullish. Out of 8 Wall Street analysts, 5 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $41.00.
How accurate are KIDS stock price projections?
Stock price projections, including those for OrthoPediatrics Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
